ID25449A - Senyawa triazin untuk pengobatan gangguan susunan syaraf pusat (cns) - Google Patents
Senyawa triazin untuk pengobatan gangguan susunan syaraf pusat (cns)Info
- Publication number
- ID25449A ID25449A IDW20001416A ID20001416A ID25449A ID 25449 A ID25449 A ID 25449A ID W20001416 A IDW20001416 A ID W20001416A ID 20001416 A ID20001416 A ID 20001416A ID 25449 A ID25449 A ID 25449A
- Authority
- ID
- Indonesia
- Prior art keywords
- cns
- disturbances
- treatment
- triazin
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726987.2A GB9726987D0 (en) | 1997-12-22 | 1997-12-22 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID25449A true ID25449A (id) | 2000-10-05 |
Family
ID=10823992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20001416A ID25449A (id) | 1997-12-22 | 1998-12-18 | Senyawa triazin untuk pengobatan gangguan susunan syaraf pusat (cns) |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6265405B1 (tr) |
| EP (1) | EP1042304A1 (tr) |
| JP (1) | JP2001526275A (tr) |
| KR (1) | KR20010024800A (tr) |
| CN (1) | CN1284951A (tr) |
| AP (1) | AP2000001846A0 (tr) |
| AR (1) | AR014146A1 (tr) |
| AU (1) | AU753874B2 (tr) |
| BR (1) | BR9814495A (tr) |
| CA (1) | CA2315620A1 (tr) |
| CO (1) | CO5011066A1 (tr) |
| EA (1) | EA200000561A1 (tr) |
| EE (1) | EE200000391A (tr) |
| GB (1) | GB9726987D0 (tr) |
| GT (1) | GT199800203A (tr) |
| HN (1) | HN1998000193A (tr) |
| HR (1) | HRP20000419A2 (tr) |
| HU (1) | HUP0100611A3 (tr) |
| ID (1) | ID25449A (tr) |
| IL (1) | IL136867A0 (tr) |
| IS (1) | IS5542A (tr) |
| JO (1) | JO2065B1 (tr) |
| MA (1) | MA26587A1 (tr) |
| NO (1) | NO20003211L (tr) |
| NZ (1) | NZ505254A (tr) |
| PA (1) | PA8465101A1 (tr) |
| PE (1) | PE20000063A1 (tr) |
| PL (1) | PL341392A1 (tr) |
| SK (1) | SK9592000A3 (tr) |
| SV (1) | SV1998000151A (tr) |
| TR (1) | TR200001970T2 (tr) |
| WO (1) | WO1999032462A1 (tr) |
| YU (1) | YU39600A (tr) |
| ZA (1) | ZA9811725B (tr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0002666D0 (en) | 2000-02-04 | 2000-03-29 | Univ London | Blockade of voltage dependent sodium channels |
| ATE359783T1 (de) * | 2001-12-27 | 2007-05-15 | Ortho Mcneil Pharm Inc | Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems |
| ES2323268T3 (es) * | 2002-07-29 | 2009-07-10 | Glaxo Group Ltd | Formulaciones de liberacion prolongada que contienen lamotrigina. |
| JP2006515326A (ja) * | 2003-01-30 | 2006-05-25 | ダイノジェン ファーマシューティカルズ， インコーポレイテッド | 胃腸管障害を処置するためのナトリウムチャネルモジュレーターの使用 |
| AR044503A1 (es) | 2003-03-18 | 2005-09-14 | Merck & Co Inc | Triazoles sustituidos con biarilo como bloqueantes del canal de sodio |
| DE10332472A1 (de) * | 2003-07-16 | 2005-02-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung von Tinnitus |
| CA2536764C (en) * | 2003-08-25 | 2013-09-17 | Newron Pharmaceuticals, S.P.A. | .alpha.-aminoamide derivatives useful as anti-inflammatory agents |
| US20060115865A1 (en) * | 2004-10-25 | 2006-06-01 | Anlong Ouyang | Lamotrigine analogs |
| GB201111712D0 (en) | 2011-07-08 | 2011-08-24 | Gosforth Ct Holdings Pty Ltd | Pharmaceutical compositions |
| EP3524605B1 (en) * | 2018-02-13 | 2019-11-27 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | New efficient process for the preparation of sitagliptin |
| CN114796146B (zh) * | 2022-04-28 | 2023-03-28 | 上海奥科达医药科技股份有限公司 | 一种拉莫三嗪的缓释制剂及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3637688A (en) | 1970-01-09 | 1972-01-25 | American Home Prod | 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines |
| EP0021120B1 (en) | 1979-06-01 | 1983-04-06 | The Wellcome Foundation Limited | 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them |
| AU530999B2 (en) | 1979-06-01 | 1983-08-04 | Wellcome Foundation Limited, The | Substituted amino triazines and their use in treatment of cns disorders |
| IT1145308B (it) | 1979-08-16 | 1986-11-05 | Wellcome Found | Composti aromatici sostituiti |
| GB8328757D0 (en) | 1983-10-27 | 1983-11-30 | Wellcome Found | Chemical compounds |
| GB9012316D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9012311D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9012312D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9203483D0 (en) | 1992-02-19 | 1992-04-08 | Wellcome Found | Anti-inflammatory compounds |
| JP3439211B2 (ja) | 1992-06-12 | 2003-08-25 | ザ ウエルカム ファウンデーション リミテッド | 薬物に対する依存性，耐性および感作の処置および予防における３，５−ジアミノ−６−（２，３−ジクロロフェニル）−１，２，４−トリアジン イセチオネートの使用 |
| AU5704594A (en) | 1992-12-18 | 1994-07-19 | Wellcome Foundation Limited, The | Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors |
| US5866597A (en) | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
| GB9305692D0 (en) | 1993-03-19 | 1993-05-05 | Wellcome Found | Therapeutic triazine compounds and use |
| GB9426448D0 (en) * | 1994-12-30 | 1995-03-01 | Wellcome Found | Process |
| FR2741879A1 (fr) | 1995-12-05 | 1997-06-06 | Esteve Labor Dr | Derives de fluorophenyl-triazines et pyrimidines, leur preparation et leur application en tant que medicament |
-
1997
- 1997-12-22 GB GBGB9726987.2A patent/GB9726987D0/en not_active Ceased
-
1998
- 1998-12-18 AR ARP980106526A patent/AR014146A1/es not_active Application Discontinuation
- 1998-12-18 EE EEP200000391A patent/EE200000391A/xx unknown
- 1998-12-18 PL PL98341392A patent/PL341392A1/xx unknown
- 1998-12-18 NZ NZ505254A patent/NZ505254A/en unknown
- 1998-12-18 AU AU24147/99A patent/AU753874B2/en not_active Ceased
- 1998-12-18 CN CN98813745A patent/CN1284951A/zh active Pending
- 1998-12-18 SK SK959-2000A patent/SK9592000A3/sk unknown
- 1998-12-18 EA EA200000561A patent/EA200000561A1/ru unknown
- 1998-12-18 HU HU0100611A patent/HUP0100611A3/hu unknown
- 1998-12-18 ID IDW20001416A patent/ID25449A/id unknown
- 1998-12-18 YU YU39600A patent/YU39600A/sh unknown
- 1998-12-18 KR KR1020007006947A patent/KR20010024800A/ko not_active Application Discontinuation
- 1998-12-18 BR BR9814495-2A patent/BR9814495A/pt not_active IP Right Cessation
- 1998-12-18 WO PCT/EP1998/008273 patent/WO1999032462A1/en not_active Application Discontinuation
- 1998-12-18 CA CA002315620A patent/CA2315620A1/en not_active Abandoned
- 1998-12-18 EP EP98966635A patent/EP1042304A1/en not_active Withdrawn
- 1998-12-18 IL IL13686798A patent/IL136867A0/xx unknown
- 1998-12-18 US US09/582,058 patent/US6265405B1/en not_active Expired - Fee Related
- 1998-12-18 SV SV1998000151A patent/SV1998000151A/es unknown
- 1998-12-18 AP APAP/P/2000/001846A patent/AP2000001846A0/en unknown
- 1998-12-18 JP JP2000525399A patent/JP2001526275A/ja active Pending
- 1998-12-18 TR TR2000/01970T patent/TR200001970T2/tr unknown
- 1998-12-18 CO CO98075403A patent/CO5011066A1/es unknown
- 1998-12-21 PA PA19988465101A patent/PA8465101A1/es unknown
- 1998-12-21 JO JO19982065A patent/JO2065B1/en active
- 1998-12-21 PE PE1998001255A patent/PE20000063A1/es not_active Application Discontinuation
- 1998-12-21 ZA ZA9811725A patent/ZA9811725B/xx unknown
- 1998-12-22 GT GT199800203A patent/GT199800203A/es unknown
- 1998-12-22 MA MA25403A patent/MA26587A1/fr unknown
-
1999
- 1999-12-21 HN HN1998000193A patent/HN1998000193A/es unknown
-
2000
- 2000-06-20 IS IS5542A patent/IS5542A/is unknown
- 2000-06-21 NO NO20003211A patent/NO20003211L/no unknown
- 2000-06-21 HR HR20000419A patent/HRP20000419A2/hr not_active Application Discontinuation
-
2001
- 2001-07-06 US US09/899,198 patent/US6465461B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI963613A0 (fi) | Polyolefiinien stabilointi | |
| NO980930D0 (no) | Arrangement av kontaktpar for kompensering for nær-ende krysstale | |
| ID24638A (id) | Senyawa-senyawa anti aritmia bispidina | |
| PL336290A1 (en) | Sulphonamides for treating endothelin-involving disorders | |
| NO20003065D0 (no) | Kombinasjon for effektiv behandling av impotens | |
| DE69719815D1 (de) | Aminoacyl sulfamiden zur behandlung hyperproliferativer störungen | |
| ID25449A (id) | Senyawa triazin untuk pengobatan gangguan susunan syaraf pusat (cns) | |
| IL117016A0 (en) | Purification of melamine | |
| DE69837705D1 (de) | Justierung von optischen komponenten | |
| ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
| FI943798A (fi) | Kasvaimenvastaisen vaikutuksen lisäämiseen tarkoitettuja heterosyklisiä yhdisteitä | |
| ID21920A (id) | 4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns | |
| ID26083A (id) | Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns | |
| ID24922A (id) | Terapi kombinasi untuk pengobatan aids | |
| NO20006383D0 (no) | Fremgangsmåte for behandling | |
| IL117813A0 (en) | Use of heterocyclic compounds | |
| IL139018A0 (en) | Paroxetine 10-camphorsulfonate for treatment of cns disorders | |
| AU7521598A (en) | Aralkoxy-morphinan derivatives for treatment of cns disorders | |
| ID24439A (id) | Penggunaan tiazolidindion untuk pengobatan hiperglikemia | |
| DE69506713D1 (de) | Chloroalkylierung von aromatischen verbindungen | |
| PT761766E (pt) | Compostos assimetricos de trifenilenodioxazina | |
| HUT65840A (en) | Methode for dewatering of gully-holes | |
| IL122077A0 (en) | Epi-inositol compositions for the treatment of CNS disorders | |
| ID24521A (id) | Penggunaan tiazolidindion untuk pengobatan hiperglikemia | |
| ID17435A (id) | Senyawa-senyawa oligonukleotida yang spesifik untuk papilomavirus manusia |